What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Diabetes mellitus
Iichiro Shimomura focuses on Internal medicine, Endocrinology, Adipose tissue, Adiponectin and Insulin resistance.
Internal medicine and Diabetes mellitus are commonly linked in his work.
His Adipose tissue study incorporates themes from Molecular biology, Messenger RNA, Glycerol and Skeletal muscle.
The Adiponectin study combines topics in areas such as Fibrosis, Peroxisome proliferator-activated receptor, Vascular disease and Scavenger receptor.
The study incorporates disciplines such as Growth factor and Triglyceride in addition to Insulin resistance.
He has included themes like Gene product and Polyclonal antibodies in his Adiponectin secretion study.
His most cited work include:
- Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. (4195 citations)
- Increased oxidative stress in obesity and its impact on metabolic syndrome (3709 citations)
- cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). (1883 citations)
What are the main themes of his work throughout his whole career to date?
Iichiro Shimomura mostly deals with Internal medicine, Endocrinology, Diabetes mellitus, Adiponectin and Type 2 diabetes.
His study in Insulin, Adipose tissue, Insulin resistance, Metabolic syndrome and Obesity falls under the purview of Internal medicine.
Iichiro Shimomura is studying Adipocyte, which is a component of Adipose tissue.
His research on Metabolic syndrome often connects related topics like Dyslipidemia.
Endocrinology is frequently linked to Gastroenterology in his study.
The concepts of his Diabetes mellitus study are interwoven with issues in Body mass index and Cardiology.
He most often published in these fields:
- Internal medicine (81.05%)
- Endocrinology (62.30%)
- Diabetes mellitus (35.08%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (81.05%)
- Diabetes mellitus (35.08%)
- Type 2 diabetes (17.94%)
In recent papers he was focusing on the following fields of study:
Iichiro Shimomura spends much of his time researching Internal medicine, Diabetes mellitus, Type 2 diabetes, Endocrinology and Type 2 Diabetes Mellitus.
His Internal medicine research integrates issues from Gastroenterology and Type 1 diabetes.
His studies deal with areas such as Body mass index and Cardiology as well as Diabetes mellitus.
Iichiro Shimomura interconnects Hypoglycemia, Observational study, Logistic regression, Kidney disease and Coronary artery disease in the investigation of issues within Type 2 diabetes.
His research in the fields of Adiponectin, Glucagon, T-cadherin and Insulin resistance overlaps with other disciplines such as Context.
His Adiponectin research focuses on Cell biology and how it connects with Adult stem cell.
Between 2018 and 2021, his most popular works were:
- T-Lymphocyte Infiltration to Islets in the Pancreas of a Patient Who Developed Type 1 Diabetes After Administration of Immune Checkpoint Inhibitors. (20 citations)
- Adiponectin, a unique adipocyte-derived factor beyond hormones (19 citations)
- Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study. (18 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Diabetes mellitus
His primary scientific interests are in Internal medicine, Type 2 diabetes, Diabetes mellitus, Endocrinology and Gastroenterology.
His studies in Type 2 diabetes integrate themes in fields like Coronary artery disease, Placebo, Overweight and First line.
In general Diabetes mellitus, his work in Type 2 Diabetes Mellitus, Type 1 diabetes and Dyslipidemia is often linked to Plasma glucagon linking many areas of study.
His is doing research in Adiponectin, Homeostasis, Insulin resistance, Islet and T-cadherin, both of which are found in Endocrinology.
His Adiponectin research also works with subjects such as
- Transplantation together with Mesenchymal stem cell, Adult stem cell and Stromal cell,
- Cell therapy together with Pioglitazone, Adipose-Derived Regenerative Cells, Peroxisome proliferator-activated receptor, Cytokine and Adipose tissue.
His Gastroenterology research is multidisciplinary, incorporating elements of Metabolome and Diabetic ketoacidosis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
